US FDA Hiring Data: CBER Exceeds CDER In Progress Toward Goals
Executive Summary
Through three-quarters of fiscal year 2023, CBER had hired nearly 70% of the mandated new PDUFA VII employees, while CDER had only hired 40%. The drug center also hired only 36% of the required new BsUFA III employees.
You may also be interested in...
Pilot Phase Of Operation Warp Speed For Rare Diseases Beginning Soon
US FDA’s biologics center intends to ask for volunteers to help demonstrate the concept, modeled on the COVID vaccine effort, which includes speedier communication with sponsors to expedite development of products for rare diseases.
Califf’s New Spin On US FDA Staffing: Attrition Rate Is Too Low
Commissioner also talks drug shortages, difficulty getting key agency and industry priorities done in new pandemic legislation, and how legal challenges to FDA authority could impact pharma companies desire to develop new medicines.
FDA Staffing: Retirements Account For More Than One-Third Of FY 2023 Departures
Combination of an aging workforce and departures that were delayed by the pandemic are taking a toll on the agency’s current staffing levels, Chief of Staff Julie Tierney says.